Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Company News

Bio-Technology General deal

WIR Staff
November 15, 1993 8:00 AM UTC

SPA will manufacture Oxandrin for sale by both companies. SPA has marketing rights in Western Europe, Eastern Europe and the former Soviet Union. BTGC retained marketing rights to all other areas. BTGC will provide clinical data to SPA for regulatory submissions in SPA's territories in exchange for royalties on SPA sales. ...